Chinese Clinical Oncology

• 综述与讲座 • Previous Articles     Next Articles

Application status and progression of thalidomide in treatment of solid tumors

WANG Nianfei, CHEN Zhendong.

  

  1. Department of Medical Oncology, the Second Hospital of Anhui Medical University, Hefei 230601, China
  • Received:2014-10-30 Revised:2014-12-07 Online:2015-03-31 Published:2015-03-31
  • Contact: CHEN Zhendong

Abstract: Thalidomide originally was used for the treatment of vomiting of pregnancy, which was once forbidden in the clinical for teratogenic events. Basic researches have confirmed that thalidomide has the effect of antiangiogenesis, immune adjustment and anti-inflammatory. Therefore, it is postulated that it has antitumor potential, as evident by the treatment of multiple myeloma. The treatment of solid tumors by thalidomide is still in the exploration stage. The existing literatures are focusing on case reports and phase Ⅰ and Ⅱ clinical study with inconsistent curative effect, needing to be further confirmed by largesample randomized controlled clinical trials. In addition, thalidomide may have a certain value to relieve the gastrointestinal reaction caused by chemotherapy and cancer anorexia cachexia syndrome.

No related articles found!
Viewed
Full text
137
HTML PDF
Just accepted Online first Issue Just accepted Online first Issue
0 0 0 0 0 137

  From local
  Times 137
  Rate 100%

Abstract
125
Just accepted Online first Issue
0 0 125
  From Others
  Times 126
  Rate 100%

Cited

Web of Science  Crossref   ScienceDirect  Search for Citations in Google Scholar >>
 
This page requires you have already subscribed to WoS.
  Shared   
  Discussed   
No Suggested Reading articles found!